Evidence map›Paper›PMID 31419935›Full record

ArticleBMC bioinformatics2019

VIST - a Variant-Information Search Tool for precision oncology.

Jurica Ševa, David Luis Wiegandt, Julian Götze, Mario Lamping, Damian Rieke, Reinhold Schäfer, Patrick Jähnichen, Madeleine Kittner, Steffen Pallarz, Johannes Starlinger and 2 more

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Clinical Interpretation of Sequence Variants.Current protocols in human genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jurica ŠevaKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany.
David Luis WiegandtKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany.
Julian GötzeUniversity Hospital Tübingen, Hoppe-Seyler-Straße 3, Tübingen, 72076, Germany.
Mario LampingCharité Comprehensive Cancer Center, Charitéplatz 1, Berlin, 10117, Germany.
Damian RiekeCharité Comprehensive Cancer Center, Charitéplatz 1, Berlin, 10117, Germany.
Reinhold SchäferCharité Comprehensive Cancer Center, Charitéplatz 1, Berlin, 10117, Germany.
Patrick JähnichenKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany.
Madeleine KittnerKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany.
Steffen PallarzKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany.
Johannes StarlingerKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany.
Ulrich KeilholzCharité Comprehensive Cancer Center, Charitéplatz 1, Berlin, 10117, Germany.
Ulf LeserKnowledge Management in Bioinformatics, Department of Computer Science, Humboldt-Universität zu Berlin, Rudower Chaussee 25, Berlin, 12489, Germany. leser@informatik.hu-berlin.de.

Funding

Bundesministerium für Bildung und Forschung 031L0030BBundesministerium für Bildung und Forschung 31L0023ACharité - Universitätsmedizin Berlin BIH-Charité Clinical Scientist ProgramDeutsche Forschungsgemeinschaft STA1471/1-1
6 · The paper itself

Abstract

backgroundDiagnosis and treatment decisions in cancer increasingly depend on a detailed analysis of the mutational status of a patient's genome. This analysis relies on previously published information regarding the association of variations to disease progression and possible interventions. Clinicians to a large degree use biomedical search engines to obtain such information; however, the vast majority of scientific publications focus on basic science and have no direct clinical impact. We develop the Variant-Information Search Tool (VIST), a search engine designed for the targeted search of clinically relevant publications given an oncological mutation profile.

resultsVIST indexes all PubMed abstracts and content from ClinicalTrials.gov. It applies advanced text mining to identify mentions of genes, variants and drugs and uses machine learning based scoring to judge the clinical relevance of indexed abstracts. Its functionality is available through a fast and intuitive web interface. We perform several evaluations, showing that VIST's ranking is superior to that of PubMed or a pure vector space model with regard to the clinical relevance of a document's content.

conclusionDifferent user groups search repositories of scientific publications with different intentions. This diversity is not adequately reflected in the standard search engines, often leading to poor performance in specialized settings. We develop a search engine for the specific case of finding documents that are clinically relevant in the course of cancer treatment. We believe that the architecture of our engine, heavily relying on machine learning algorithms, can also act as a blueprint for search engines in other, equally specific domains. VIST is freely available at https://vist.informatik.hu-berlin.de/.

Indexed as

Precision MedicineSearch EngineAlgorithmsDatabases as TopicDocumentationHumansInternetNeoplasmsUser-Computer InterfaceBiomedical information retrievalClinical relevanceDocument classificationDocument retrievalDocument triagePersonalized oncology

Identifiers

PMID31419935
PMCPMC6697931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.